Oxidative Stress (Cardiovascular)

Oxidative Stress (Cardiovascular)

Reactive oxygen species are ordinary products of aerobic metabolism, generated continuously by the mitochondrial respiratory chain and by enzymes including NADPH oxidase and xanthine oxidase. They also function as signalling molecules. Oxidative stress describes the state in which their production outpaces the antioxidant systems that contain them, and in cardiovascular tissue the consequences are specific: nitric oxide is scavenged before it can act as a vasodilator, LDL particles are modified into forms that macrophages ingest readily, and the endothelium loses regulatory control over vessel tone. Elevated biomarkers, among them F2-isoprostanes, oxidised LDL and malondialdehyde, are measurable in more than 80 percent of patients with cardiovascular disease.

The condition has no symptoms of its own. It is inferred from laboratory markers and from the vascular changes it accompanies, chiefly endothelial dysfunction and arterial stiffness. That indirect character shapes the evidence: trials must select a biomarker as their endpoint and then argue that moving it matters.

Only two ingredients are graded against this endpoint here, on five studies and 700 participants between them, which is the narrowest evidence base of any cardiovascular condition in the collection.

Selenium holds Grade B on 3 studies and 600 participants. Its rationale is unusually direct, since the element is incorporated as selenocysteine into glutathione peroxidases and thioredoxin reductases, the enzymes that reduce hydrogen peroxide and lipid hydroperoxides. It is therefore not an antioxidant by chemical reactivity but a structural requirement of the antioxidant enzymes themselves, a distinction reviewed at length in the nutritional literature ^[1] and in surveys of its role across chronic disease ^[2].

Selenium also demonstrates why more is not better. Its intake-response relationship is U-shaped rather than linear. Rodent work has reported myocardial fibrosis at both deficient and modestly supplemented intakes, attributed to effects on redox-methylation balance ^[3], and the epidemiological relationship between selenium status and type 2 diabetes has resisted a simple reading for the same reason ^[4]. Baseline status determines whether supplementation is a correction or an excess, and soil selenium content varies enough between regions that population averages are a poor guide to individuals.

PQQ holds Grade C on 2 studies and 100 participants. Its proposed mechanism concerns mitochondrial biogenesis and the sirtuin signalling pathway rather than direct radical scavenging ^[5], which places it in a different category from a conventional antioxidant.

A broader caution applies to the whole endpoint. Reactive oxygen species generated during exercise are part of the signal that drives adaptation, and high-dose antioxidant supplementation has been examined for its capacity to blunt that response ^[6]. Suppressing a signalling system is not equivalent to correcting a deficiency. Smoking, air pollution, excess alcohol, high-fat diets, diabetes and chronic inflammation remain the drivers with the clearest relationship to the biomarkers in question.